After finishing at $1.37 in the prior trading day, Opko Health Inc (NASDAQ: OPK) closed at $1.35, down -1.46%. In other words, the price has decreased by -$1.46 from its previous closing price. On the day, 1.72 million shares were traded. OPK stock price reached its highest trading level at $1.38 during the session, while it also had its lowest trading level at $1.34.
Ratios:
Our goal is to gain a better understanding of OPK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.28.
On June 29, 2023, Barrington Research Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $2.
On December 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $3.H.C. Wainwright initiated its Buy rating on December 15, 2022, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 10 ’25 when FROST PHILLIP MD ET AL bought 125,000 shares for $1.36 per share. The transaction valued at 169,712 led to the insider holds 214,001,448 shares of the business.
FROST PHILLIP MD ET AL bought 125,000 shares of OPK for $184,650 on Apr 08 ’25. The CEO & Chairman now owns 213,876,448 shares after completing the transaction at $1.48 per share. On Apr 01 ’25, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 100,000 shares for $1.65 each. As a result, the insider paid 164,850 and bolstered with 213,751,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPK now has a Market Capitalization of 1070621568 and an Enterprise Value of 1134678272. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.55 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 1.646 whereas that against EBITDA is -6.543.
Stock Price History:
The Beta on a monthly basis for OPK is 1.20, which has changed by -0.055944085 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, OPK has reached a high of $2.04, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is 0.75%, while the 200-Day Moving Average is calculated to be -9.96%.
Shares Statistics:
The stock has traded on average 3.20M shares per day over the past 3-months and 2699330 shares per day over the last 10 days, according to various share statistics. A total of 671.61M shares are outstanding, with a floating share count of 350.18M. Insiders hold about 55.84% of the company’s shares, while institutions hold 31.96% stake in the company. Shares short for OPK as of 1752537600 were 32409499 with a Short Ratio of 10.13, compared to 1749772800 on 30996173. Therefore, it implies a Short% of Shares Outstanding of 32409499 and a Short% of Float of 6.9699995.
